Pathology Focus
2022

In the October edition of Pathology Focus Dr Stella Pendle provides clinical insights for the testing and management of monekypox virus and Dr Catherine Uzzell shares recent changes for self-collect HPV testing. Assoc. Prof. Mirette Saad, National Director of Molecular Genetics, discusses the advantages of utilising liquid biopsy as part of the ongoing management and treatment of patients living with cancer. Our October edition concludes with a reminder from Assoc. Prof. Chris Barnes on the importance of out-of-hours contacts for critical pathology results.

VIC/QLD    NSW/ACT    SA/NT    WA

In our June 2022 edition of Pathology Focus Dr David Deam looks at the prevalence of new type 2 diabetes, in pre-diabetic/at risk patients, following COVID-19 infection. Also included, is an article by Dr Tony Mak proposing a collaborative approach to the diagnosis of primary aldosteronism in hypertensive patients, with the use of Aldosterone/Renin Ratio testing. The newsletter concludes with a GP Connect Q&A, between Clinical Labs immunopathologist Associate Professor Louise Smyth and General Practitioner Dr Greg Caddy, on the significance of DFS70 in relation to ANA results.

VIC/QLD    NSW/ACT    SA/NT    WA

In our March 2022 edition of Pathology Focus, Clinical Labs Microbiologist and Infectious Disease Physician, Dr Nomvuyo Mothobi, provides her projections for influenza, RSV and other seasonal respiratory viruses for 2022. Also included, is a topical article by Assoc. Prof. Chris Barnes on recovery following COVID-19 infection and how investigative pathology tests can help. The newsletter concludes with a patient specimen case study, on radiation gastropathy associated atypia by Clinical Labs anatomical pathologists, Dr Adha Malik and Dr Bryn Atmore.  

VIC    NSW/ACT    SA/NT    WA